Overview
The Best of Small Cell Lung Cancer Conference (SCLC) 2025 Webinar provides medical professionals and researchers with a comprehensive view of the latest advancements in understanding and treating this aggressive disease. Sessions covering diverse topics—from pathology and pulmonary neuroendocrine neoplasms to cutting-edge epigenetics and novel therapeutic approaches—offer attendees unique insights into both the biological underpinnings and clinical treatment options. By focusing on immunotherapy, cell surface targeting, and the role of mouse models, the webinar aims to equip lab researchers and medical oncologists with the knowledge they need to innovate and improve patient outcomes.
- Identify and describe recent preclinical and clinical advances in small cell lung cancer (SCLC) research.
- Understand the current state of basic research concerning the oncogenesis and biology of small cell lung cancer.
- Understand the importance of collaboration and the generation of new ideas within the SCLC research community.
The IASLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
IASLC designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- Identify and describe recent preclinical and clinical advances in small cell lung cancer (SCLC) research.
- Understand the current state of basic research concerning the oncogenesis and biology of small cell lung cancer.
- Understand the importance of collaboration and the generation of new ideas within the SCLC research community.
The IASLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
IASLC designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Share
Participants
Anish Thomas
MBBS, MD
National Cancer Institute
Kristin Lastwika
PhD
Fred Hutch Cancer Center
Christin Kuo
MD
Stanford Medicine
Trudy Oliver
PhD
Duke University School of Medicine
Jacob Sands
MD
Assistant Professor of Medicine, Harvard Medical School
Lowe Cancer Center for Thoracic Oncology
Dana Farber Cancer Institute